Six-Month Outcomes in 1,048 Occupational-Skin Patients
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: How did six-month clearing differ after work changes in 1,048 diagnosed patients?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 1,048 patients diagnosed with occupational skin disease at the Finnish Institute of Occupational Health after examinations conducted from 1994 through 2001. |
| Design | Follow-up questionnaire study analyzing medical and occupational outcomes and prognostic factors. |
| Comparator | Outcomes were compared between patients with no work change and those who changed job or occupation, and across diagnosis and risk-factor groups. |
| Timepoint | Six months after diagnosis. |
| Key result | Skin disease had healed in 27% overall, 17% with no work changes and 34% after a job or occupation change. Clearing was 35% for contact urticaria, 27% for allergic dermatitis and 23% for irritant dermatitis. |
| Funding/conflict context | The indexed abstract does not state funding or conflicts. The study was not a moisturizer trial. |
What was actually measured?
Skin disease had healed in 27% overall, 17% with no work changes and 34% after a job or occupation change. Clearing was 35% for contact urticaria, 27% for allergic dermatitis and 23% for irritant dermatitis.
Better outcomes after work change are consistent with exposure removal, but nonrandom work changes may reflect prognosis, opportunity and disease severity.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
Questionnaire follow-up, nonrandomized exposure changes, older referral cohort, loss-to-follow-up details absent from the abstract and residual confounding limit causal claims.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 19878240
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Hand-Eczema Patch Tests in 788 of 4,438 Shanghai Patients
- Objective Skin-Barrier Measures in 185 Physicians, Dentists and Controls
- Metal Sensitization and Occupation Across 14,464 Patients
- Building an Australian Baseline Patch Series From 5,281 Patients
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.